EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

Quantifying multimodal longitudinal brain changes in presymptomatic C9orf72 disease

Dario Saracino, Lorenzo Cipriano, Marion Houot, Giorgia Querin, Daisy Rinaldi, Armelle Rametti-Lacroux, David Wallon, Emmanuel Gerardin, Philippe Couratier, Marie-Paule Boncoeur, Thibaud Lebouvier, PREV‐DEMALS and STRATALS study groups und 4 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70902 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Dario Saracino und 15 weiteren Autor:innen. Beteiligte Einrichtung: Paris Brain Institute-Institut du Cerveau-ICM, Sorbonne Université, Inserm U1127, CNRS UMR 7225, AP-HP-Hôpital Pitié-Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Brain, C9orf72 Protein, Frontotemporal Dementia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ANR/DGOS - Assistance Publique-Hôpitaux de Paris (Dr Le Ber), Agence Nationale de la Recherche (Dr Le Ber), JPND/ANR (Dr Pradat and Dr Le Ber).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The presymptomatic phase of frontotemporal dementia and amyotrophic lateral sclerosis associated with C 9orf72 repeat expansion features widespread structural brain changes. We aimed at fulfilling the unmet need of quantitative magnetic resonance imaging (MRI)‐derived measures suitable for disease tracking. METHODS We compared the profile of longitudinal gray (GM) and white matter (WM) changes in 66 presymptomatic carriers and 52 controls over 3‐year follow‐up and appraised their annualized rate of change (ARC). RESULTS Both putamen ( p < 0.01) and left insula ( p = 0.005) volumes declined the most in carriers over 40, with an ARC up to four‐fold higher than in controls. Increases in mean diffusivity occurred first in the left uncinate fasciculus, followed by thalamo‐cortical bundles ( p < 0.05), associated with higher neurofilament levels. DISCUSSION Our study highlighted the GM and WM structures showing the greatest longitudinal decline during the preclinical stage, whose ARC may serve as an MRI‐derived biomarker for longitudinal surveillance and therapeutic outcome. CLINICAL TRIAL REGISTRATION NCT02590276 and NCT05358431. Highlights We studied longitudinal multimodal MRI changes in presymptomatic C9orf72 disease. Carriers displayed faster atrophy in putamen, insula and cerebellar regions. Mean diffusivity increased mainly in uncinate and thalamo‐cortical tracts. These differences were even more significant in older (> 40) participants. We proposed targeted annualized rate of change as a quantitative biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisBrainC9orf72 ProteinFrontotemporal DementiaGray MatterWhite MatterAgedFemaleHumansMaleMiddle AgedDisease ProgressionLongitudinal StudiesMagnetic Resonance Imaging

Stichwörter der Autor:innen

C9orf72amyotrophic lateral sclerosis (ALS)basal gangliabiomarkerclinical trialsdiffusion tensor imaging (DTI)frontotemporal dementia (FTD)frontotemporal lobar degeneration (FTLD)geneticlongitudinalmagnetic resonance imaging (MRI)neurofilamentsneuroimagingpresymptomaticvoxel‐based morphometry

Substanzen

C9orf72 ProteinC9orf72 protein, human

Autor:innen und Institutionen

  • Paris Brain Institute-Institut du Cerveau-ICM, Sorbonne Université, Inserm U1127, CNRS UMR 7225, AP-HP-Hôpital Pitié-Salpêtrière, Paris, France.
  • Reference Centre for Rare or Early-Onset Dementias, IM2A, Département de Neurologie, AP-HP-Hôpital Pitié-Salpêtrière, Paris, France.
  • Inserm U1127, CNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau-ICM, FRONTlab, Paris, France.
  • Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, CIC Neurosciences, Département de Neurologie, AP-HP-Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.
  • Reference Center for ALS, Département de Neurologie, AP-HP-Hôpital Pitié-Salpêtrière, Paris, France.
  • Biomedical Imaging Laboratory (LIB), CNRS, INSERM, Sorbonne Université, Paris, France.

ORCID-Profile: Isabelle Le Ber

Förderung

  • ANR/DGOS - Assistance Publique-Hôpitaux de Paris (Dr Le Ber)
  • Agence Nationale de la Recherche (Dr Le Ber)
  • JPND/ANR (Dr Pradat and Dr Le Ber)
  • Agence Nationale de la Recherche as part of the "France 2030" program
  • Agence Nationale de la Recherche as part of the "Investissements d'avenir" program
  • European Union's HORIZON EUROPE Framework Programme

Zitieren

APA

Saracino, D., Cipriano, L., Houot, M., Querin, G., Rinaldi, D., Rametti-Lacroux, A., Wallon, D., Gerardin, E., Couratier, P., Boncoeur, M. P., Lebouvier, T., PREV‐DEMALS and STRATALS study groups, Colliot, O., Pradat, P. F., Migliaccio, R., & Le Ber, I. (2025). Quantifying multimodal longitudinal brain changes in presymptomatic C9orf72 disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70902

Vancouver

Saracino D, Cipriano L, Houot M, Querin G, Rinaldi D, Rametti-Lacroux A, et al. Quantifying multimodal longitudinal brain changes in presymptomatic C9orf72 disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70902

BibTeX
@article{Saracino2025,
  author = {Saracino, Dario and Cipriano, Lorenzo and Houot, Marion and Querin, Giorgia and Rinaldi, Daisy and Rametti-Lacroux, Armelle and Wallon, David and Gerardin, Emmanuel and Couratier, Philippe and Boncoeur, Marie-Paule and Lebouvier, Thibaud and PREV‐DEMALS and STRATALS study groups, PREV‐DEMALS and STRATALS study groups and Colliot, Olivier and Pradat, Pierre-François and Migliaccio, Raffaella and Le Ber, Isabelle},
  title = {Quantifying multimodal longitudinal brain changes in presymptomatic C9orf72 disease},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70902}
}
Kostenlos starten →